Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 12 - 06 save search
Merck Announces Pause in Enrollment for Two Phase 3 Clinical Trials of Investigational, Once-Monthly, Oral Islatravir for Pre-Exposure Prophylaxis (PrEP) of HIV-1 infection
Published: 2021-12-06 (Crawled : 23:00) - biospace.com/
MRK | $126.88 -0.05% 0.43% 4.7M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
trials trial clinical trials infection phase 3 hiv enroll infections
Acadia Pharmaceuticals Announces Positive Top-line Results from the Pivotal Phase 3 Lavender Trial of Trofinetide in Rett Syndrome
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
ACAD | News | $16.74 -1.47% -1.52% 1.5M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
trial positive results phase 3 syndros topline rett syndrome
Ventyx Biosciences Announces First Patient Dosed in a Phase 2 Clinical Trial of VTX002 for the Treatment of Moderate-to-Severe Ulcerative Colitis
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
VTYX | $4.35 1.16% 1.38% 380K
|
Manufacturing
|
| O: -1.39%
H: 0.0%
C: 0.0%
treatment phase 2 trial bioscience ulcerative colitis
IO Biotech Announces Third Clinical Collaboration with Merck to Evaluate IO102-IO103 in Combination With KEYTRUDA® (pembrolizumab) as First-Line Treatment in a Phase 2 Multi-Arm Basket Trial
Published: 2021-12-06 (Crawled : 22:00) - biospace.com/
IOBT | $1.47 2.08% -0.35% 59K
|
|
| O: -5.23%
H: 0.0%
C: 0.0%
treatment phase 2 trial keytruda collaboration biotech iot
Industrial Degreaser Market Size by Revenue to Reach USD 24.3 Billion by 2026 - Arizton
Published: 2021-12-06 (Crawled : 22:00) - prnewswire.com
SCL | $85.25 0.59% 0.0% 69K
|
Process Industries
|
| O: 4.04%
H: 0.0%
C: -2.36%
trial
Trials Show Hope on the Horizon for Dravet Syndrome, Glioblastoma
Published: 2021-12-06 (Crawled : 19:00) - biospace.com/
KZIA | $0.395 4.78% -2.45% 130K
|
Health Technology
|
| O: -16.26%
H: 0.0%
C: 0.0%
trials trial syndros glioblastoma dravet syndrome
PDS Biotech Provides Recruitment update for National Cancer Institute-Led Phase 2 Clinical Trial of PDS0101-Based CombinationInstitutional Review Board (IRB) approval has been obtained and clinical trial recruitment resumes
Published: 2021-12-06 (Crawled : 15:30) - biospace.com/
PDSB | $3.2 7.02% 6.56% 990K
|
Health Technology
|
| O: -2.14%
H: 0.0%
C: 0.0%
phase 2 trial approval cancer biotech iot
Fulcrum Therapeutics® Announces Additional HBG mRNA Induction from Higher Dose Cohorts in Phase 1 Healthy Adult Volunteer Trial of FTX-6058 for Sickle Cell Disease and New Preclinical Mechanism Data
Published: 2021-12-06 (Crawled : 15:00) - biospace.com/
FULC | $7.44 2.62% 2.62% 510K
|
Health Technology
|
| O: -0.78%
H: 0.0%
C: 0.0%
trial therapeutics disease preclinical phase 1 pre-clinical
End Suction Pump Market to Exceed US$ 6.08 by 2031 with Industrial Sector Contributing 3/4th of Overall Sales: FMI
Published: 2021-12-06 (Crawled : 14:30) - prnewswire.com
XYL | News | $130.72 1.35% -0.02% 950K
|
Producer Manufacturing
|
| O: 1.39%
H: 0.0%
C: 0.0%
FLS | $47.08 2.26% 1.08% 530K
|
Producer Manufacturing
|
| O: 1.45%
H: 0.0%
C: 0.0%
sales trial
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages ReneSola Ltd. (SOL) Investors to Contact Firm's Attorneys, Firm Investigating Possible Securities Law Violations
Published: 2021-12-06 (Crawled : 14:30) - prnewswire.com
SOL | $1.69 6.29% 0.0% 360K
|
Electronic Technology
|
| O: -11.48%
H: 0.0%
C: 0.0%
DOCU | $56.71 1.56% 1.6% 1.3M
|
Technology Services
|
| O: 0.41%
H: 0.0%
C: 0.0%
trial
NCI-Sponsored Trial of Uproleselan in Older, Newly Diagnosed AML Patients Fit for Intensive Chemotherapy Completes Enrollment of Phase 2 Portion Ahead of Schedule
Published: 2021-12-06 (Crawled : 14:30) - biospace.com/
GLYC | $1.835 1.94% 1.91% 1.2M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
phase 2 trial therapy enroll order aml
NRx Announces Completion of Data Safety Meeting for Phase 2 Trial of BriLife Vaccine, Phase 2b/3 Registration Trial to Begin in Nation of Georgia, Israel, European Union, and Other Regions
Published: 2021-12-06 (Crawled : 14:30) - globenewswire.com
NRXP 5 d | $3.05 1.67% 3.23% 100K
|
Manufacturing
|
| O: -1.09%
H: 0.0%
C: 0.0%
israel phase 2 europe phase 2b trial vaccine brilife
Jaguar Health to Host Scientific Discussion about Cancer Therapy-Related Diarrhea in Breast Cancer and the Company’s Ongoing OnTarget Pivotal Phase 3 Trial at San Antonio Breast Cancer Symposium (SABCS 2021)
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
JAGX | News | $0.168 -6.62% -6.39% 38M
|
Health Technology
|
| O: -5.69%
H: 0.0%
C: 0.0%
ongoing trial diarrhea therapy cancer phase 3 breast cancer symposium
Acurx Announces First Patient Enrolled in Phase 2b Clinical Trial of its Lead Antibiotic for Treatment of Clostridioides difficile Infection (CDI)
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
ACXP | $2.04 3.03% -2.29% 30K
|
Professional, Scientific, and T...
|
| O: 2.41%
H: 4.47%
C: 2.82%
treatment phase 2 phase 2b trial infection iot enroll infections
GH Research Announces Successful Outcome of the Phase 2 part of its Phase 1/2 Clinical Trial of GH001 in Treatment-Resistant Depression
Published: 2021-12-06 (Crawled : 14:00) - biospace.com/
GHRS | $11.3 -3.58% -3.08% 42K
|
Manufacturing
|
| O: 0.05%
H: 29.33%
C: 21.8%
treatment phase 2 research trial phase 1 depression
Biohaven Reports Positive Topline Results from Pivotal Migraine Trial of Intranasal Zavegepant Demonstrating Ultra-Rapid Pain Relief by 15 minutes; Prepares for Submission of New Drug Application
Published: 2021-12-06 (Crawled : 13:30) - biospace.com/
BHVN | News 0 d | $39.61 3.34% 5.98% 1.9M
|
Health Technology
|
| O: -5.67%
H: 0.0%
C: 0.0%
new drug application drug trial migraine topline results positive results topline pain relief submission
180 Life Sciences Provides Follow-Up Information on Oxford University and the Company’s Successful Dupuytren’s Phase 2b Clinical Trial Results
Published: 2021-12-06 (Crawled : 13:30) - globenewswire.com
ATNF | $1.9 5.56% 12.62% 48K
|
|
| O: -8.71%
H: 0.0%
C: 0.0%
phase 2 phase 2b trial trial results ford results life science
Kronos Bio Announces First Patient Dosed in AGILITY Phase 3 Clinical Trial of Entospletinib in Patients With Newly Diagnosed NPM1-mutated Acute Myeloid Leukemia
Published: 2021-12-06 (Crawled : 12:30) - globenewswire.com
KRON | $0.95 -1.04% -0.49% 4.3M
|
Health Technology
|
| O: 0.83%
H: 0.0%
C: 0.0%
myeloid leukemia leukemia trial phase 3 acute myeloid leukemia
Sierra Oncology Announces Investor Event to Review MOMENTUM Trial Design and Available Phase 3 Momelotinib Data in Myelofibrosis
Published: 2021-12-06 (Crawled : 12:30) - biospace.com/
SRRA | $54.99 0.04% 0.0%
|
Health Technology
|
| O: 3.15%
H: 0.0%
C: 0.0%
fibrosis trial phase 3 designation
Ocular Therapeutix™ Announces Topline Results for Phase 2 Clinical Trial of OTX-DED for the Short-Term Treatment of Dry Eye Disease
Published: 2021-12-06 (Crawled : 12:00) - ocutx.gcs-web.com
OCUL | News | $5.0 -1.48% -1.5% 2.3M
|
Health Technology
|
| O: -5.26%
H: 0.0%
C: 0.0%
dry eye treatment phase 2 eye ocular eye disease trial disease topline results results topline
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.